We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
SUS.ST

Price
125.00
Stock movement down
-1.60 (-1.26%)
Company name
Surgical Science Sweden AB
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Health Information Services
Market cap
6.38B
Ent value
6.07B
Price/Sales
7.42
Price/Book
1.43
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
32.99
Forward P/E
24.01
PEG
-
EPS growth
-
1 year return
-16.11%
3 year return
-16.56%
5 year return
59.37%
10 year return
-
Last updated: 2025-04-18

DIVIDENDS

SUS.ST does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E32.99
Price to OCF53.09
Price to FCF87.38
Price to EBITDA44.22
EV to EBITDA42.05

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales7.42
Price to Book1.43
EV to Sales7.05

FINANCIALS

Per share

Loading...
Per share data
Current share count51.03M
EPS (TTM)3.79
FCF per share (TTM)1.43

Income statement

Loading...
Income statement data
Revenue (TTM)859.83M
Gross profit (TTM)548.32M
Operating income (TTM)155.23M
Net income (TTM)193.34M
EPS (TTM)3.79
EPS (1y forward)5.21

Margins

Loading...
Margins data
Gross margin (TTM)63.77%
Operating margin (TTM)18.05%
Profit margin (TTM)22.49%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash666.33M
Net receivables130.84M
Total current assets1.08B
Goodwill3.34B
Intangible assets289.06M
Property, plant and equipment0.00
Total assets4.80B
Accounts payable0.00
Short/Current long term debt0.00
Total current liabilities243.82M
Total liabilities353.30M
Shareholder's equity4.45B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)120.15M
Capital expenditures (TTM)47.16M
Free cash flow (TTM)73.00M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity4.35%
Return on Assets4.03%
Return on Invested Capital4.35%
Cash Return on Invested Capital1.64%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open126.00
Daily high127.50
Daily low123.50
Daily Volume37K
All-time high330.00
1y analyst estimate192.17
Beta0.97
EPS (TTM)3.79
Dividend per share-
Ex-div date2 Nov 2023
Next earnings date16 May 2025

Downside potential

Loading...
Downside potential data
SUS.STS&P500
Current price drop from All-time high-62.12%-14.12%
Highest price drop-66.33%-56.47%
Date of highest drop7 Apr 20259 Mar 2009
Avg drop from high-28.93%-11.07%
Avg time to new high22 days12 days
Max time to new high860 days1805 days
COMPANY DETAILS
SUS.ST (Surgical Science Sweden AB) company logo
Marketcap
6.38B
Marketcap category
Mid-cap
Description
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a powerful training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was incorporated in 1997 and is headquartered in Gothenburg, Sweden.
Employees
265
Investor relations
-
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
In recent weeks, European markets have experienced heightened volatility due to escalating trade tensions, with major indices such as the STOXX Europe 600 Index seeing declines. Amid this uncertainty,...
April 16, 2025
As European markets navigate the complexities of U.S. trade tariffs and monetary policy uncertainties, investors are keenly observing how these macroeconomic factors might influence growth opportuniti...
March 18, 2025
As global markets continue to navigate the complexities of rising inflation and interest rate expectations, U.S. stock indexes are climbing toward record highs, with growth stocks outpacing value shar...
February 19, 2025
As global markets experience a mix of optimism and caution, with U.S. stock indexes nearing record highs and inflation data prompting discussions on interest rate policies, investors are keenly observ...
February 17, 2025
As global markets show signs of optimism with cooling inflation and strong earnings reports, major U.S. stock indexes have rebounded, particularly favoring value stocks over growth shares. In this env...
January 21, 2025
As global markets navigate a choppy start to the year, with U.S. equities facing pressure from inflation concerns and political uncertainties, investors are keenly observing how insider ownership migh...
January 17, 2025
In the current global market environment, characterized by cautious Federal Reserve commentary and looming political uncertainties, investors are navigating a landscape of mixed economic signals. Desp...
December 23, 2024
As global markets navigate a landscape marked by interest rate adjustments and mixed economic signals, growth stocks have continued to outperform their value counterparts, particularly in the technolo...
December 19, 2024
In November 2024, global markets are navigating a landscape marked by policy uncertainties from the incoming Trump administration and fluctuating interest rate expectations, which have influenced sect...
November 19, 2024
As European markets respond positively to recent interest rate cuts by the European Central Bank, Swedish investors are keenly observing opportunities in growth stocks that may benefit from a more acc...
October 21, 2024
Next page